If you liked this article you might like

Celgene Beats Estimates, Raises Earnings Outlook

Celgene Beats Estimates, Raises Earnings Outlook

Jim Cramer Says Oncology Drug Franchises Helping Both Celgene and Bristol-Myers

Jim Cramer Says Oncology Drug Franchises Helping Both Celgene and Bristol-Myers

Pre-Market Activity Shows Gains For Celgene (CELG)

Pre-Market Activity Shows Gains For Celgene (CELG)

Celgene Second-Quarter Earnings Yield No Surprises, Small Guidance Bump

Celgene Second-Quarter Earnings Yield No Surprises, Small Guidance Bump